Provided by Tiger Trade Technology Pte. Ltd.

Blackline Inc.

31.98
+0.15000.47%
Post-market: 31.980.00000.00%19:30 EDT
Volume:851.84K
Turnover:27.30M
Market Cap:1.86B
PE:56.81
High:32.58
Open:31.84
Low:31.76
Close:31.83
52wk High:59.57
52wk Low:24.70
Shares:58.13M
Float Shares:44.10M
Volume Ratio:0.92
T/O Rate:1.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5629
EPS(LYR):0.3900
ROE:7.03%
ROA:1.64%
PB:5.88
PE(LYR):82.00

Loading ...

BlackLine Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 01

BlackLine price target lowered to $50 from $68 at Morgan Stanley

TIPRANKS
·
May 01

3 Stocks Estimated To Be Trading At Discounts Of Up To 45.3%

Simply Wall St.
·
May 01

Earning Preview: BlackLine Inc. this quarter’s revenue is expected to increase by 8.60%, and institutional views are cautious

Earnings Agent
·
Apr 29

BlackLine Price Target Maintained With a $70.00/Share by Citizens

Dow Jones
·
Apr 28

Assessing BlackLine (BL) Valuation After A Sharp Multi Month Share Price Pullback

Simply Wall St.
·
Apr 27

BlackLine Bets On Agentic AI To Deepen Control For Finance Teams

Simply Wall St.
·
Apr 24

BlackLine Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Apr 14

BlackLine launches AI Innovation Hub in New York to accelerate trusted finance AI

Reuters
·
Apr 14

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

Blackline files Form 3 initial beneficial ownership statement; director Megan Prichard reports no securities beneficially owned

Reuters
·
Mar 27

Blackline files initial beneficial ownership statement; director Duncan Storm reports no securities beneficially owned

Reuters
·
Mar 27

BlackLine announces annual stockholder meeting; FY2025 GAAP revenue rises 7.2% to $700 million

Reuters
·
Mar 25

BlackLine Founder Therese Tucker to Retire From Executive Role

MT Newswires Live
·
Mar 25

Press Release: BlackLine Founder Therese Tucker Announces Retirement from Full-Time Executive Role

Dow Jones
·
Mar 25

Biokin Pharmaceutical Gets Nod to Trial BL-ARC002 Injection; Shares Down 4%

MT Newswires Live
·
Mar 23

Biokin Pharmaceutical's Innovative Drug BL-ARC002 Injection Receives Clinical Trial Authorization

Stock News
·
Mar 22

13D Filings -- Barrons.com

Dow Jones
·
Mar 21

Blackline Safety Corp. published transcript of its Q1 fiscal 2026 results conference call

Reuters
·
Mar 20

Why BlackLine (BL) Is Up 5.6% After Expanding Buyback And Adding Activist-Backed Directors – And What's Next

Simply Wall St.
·
Mar 19